Antigen specific immunotherapy: Quo vadis?
Nestle
Frank O
FO
D000951:Antigens, Neoplasm / Q000276:immunology*; D019496:Cancer Vaccines / Q000276:immunology; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D013557:Switzerland
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines